T1D Exchange

T1D Exchange is a nonprofit dedicated to improving outcomes for the entire T1D population through driving real-world evidence and collaborative change.

[T1D Exchange @T1DExchange]

Your experiences matter. By sharing your perspective, answering Question of the Day, participating in #research, and engaging with our community, you're helping drive progress in #T1D.

Stay connected: https://t.co/cePscwogcI

[T1D Exchange @T1DExchange]

Researchers are studying a nighttime injection to see if it can reduce overnight lows.

Adults 18-75 with T1D for over 5 years might be eligible for the clinical trial for this new treatment.

10 new U.S. locations are now open! 🌟

See if you're eligible: https://t.co/UzU9HTlCFd

[T1D Exchange @T1DExchange]

After 13 years of living with #T1D, Katie Beth Hand did something she never imagined possible: She stopped taking #insulin.

Read her full story now: https://t.co/kaw74N6nRW

#clinicaltrial #diabetesresearch

[T1D Exchange @T1DExchange]

Do you have T1D and a history of severe lows?

Vertex Pharmaceuticals’ VX-880-101 clinical trial is currently recruiting people with T1D ages 18-65. This study is evaluating an investigational islet cell therapy in T1D.

See if you may be eligible: https://t.co/7Mexyh08s7

[T1D Exchange @T1DExchange]

We are excited to share that T1D Exchange has launched a refreshed #brand and new website.

The update reflects how we work today—bringing together real-world data, research, and community insight to improve care for people living with #type1diabetes.
➡️https://t.co/KHGV0PRyRQ

[T1D Exchange @T1DExchange]

We’re excited to introduce the T1D Exchange Medical & Research Advisory Team — leading diabetes experts helping shape the future of T1D care through research, innovation, and quality improvement.

Learn more: https://t.co/KTTVjYtB2u

[T1D Exchange @T1DExchange]

Survey opportunity! Researchers are looking for youth with T1D who are not going to a summer camp specifically for kids with diabetes this year. Families who participate will take a series of quick surveys. See if you’re eligible: https://t.co/qwiOvX12wV

[T1D Exchange @T1DExchange]

Technology has transformed #T1D management — but there’s still more work ahead.

In our latest Meet the Expert feature, Jennifer Sherr, MD, shares insights on innovation, quality improvement, and the future of diabetes care.

https://t.co/wvRZUWbjWo

[T1D Exchange @T1DExchange]

Your experience with type 1 diabetes matters.

Join the T1D Exchange Registry to share what life with T1D really looks like—through quick surveys and optional research opportunities.

23,000+ people are already in!

Make your voice heard: https://t.co/S1mCrB1Orf

[T1D Exchange @T1DExchange]

GLP-1 medications are gaining traction in the T1D community. Check out what you need to know from expert Diana Isaacs, who breaks down the real-world benefits and risks of GLP-1 medications in type 1 diabetes.

https://t.co/dQsDkqPZi8

[T1D Exchange @T1DExchange]

The VX-880-101 clinical trial is still enrolling participants!

This study tests an investigational cell therapy for people with #T1D and severe lows/impaired awareness of lows.

Learn more and check eligibility: https://t.co/WGytRIRZ4b

[T1D Exchange @T1DExchange]

Living with #T1D and experiencing nighttime lows?

You could be eligible for a study targeting overnight hypoglycemia.

- 10 new locations opened!
- 18-75 years old
- Must have T1D for 5+ years

👉 Interested? Complete the questionnaire: https://t.co/mmI0reTKIC

[T1D Exchange @T1DExchange]

New study sites added! If you are an adult with T1D and you have recently experienced low blood glucose levels, you may now qualify for a clinical trial studying a drug that may help reduce lows and lower A1C.

Find a study site near you and learn more: https://t.co/LD4CRrdU1x

[T1D Exchange @T1DExchange]

Good news for families navigating early-stage type 1 diabetes (T1D)!

The U.S. FDA has now approved teplizumab (Tzield) for children as young as 1 year old with stage 2 T1D, with the goal of delaying progression to stage 3.

Learn more from Sanofi:
https://t.co/6HX7LW0em1

[T1D Exchange @T1DExchange]

Caring for a child with T1D comes with lessons no textbook can teach.

Share your family’s experience through the T1D Exchange Registry to help improve care for people with T1D. Your story can pave the way for future research advancements. Join us today: https://t.co/k6YC2672Ck

[T1D Exchange @T1DExchange]

New study opportunity! Researchers are looking for youth with #T1D ages 8 to 17 who are not attending a diabetes camp this summer -- and their caregivers -- to take a series of brief surveys.

Learn more: https://t.co/exuaFNuycy

[T1D Exchange @T1DExchange]

Are you experiencing nighttime lows with #T1D?

You may qualify for a Phase 2 clinical trial for an investigational medication.

- Ages 18-75
- Living with T1D for 5+ years

📍 10 new study locations!

Take our quick questionnaire: https://t.co/SE1xdn0A20

[T1D Exchange @T1DExchange]

The T1DX-QI Leadership Committee brings together experts across 60+ centers to turn insights into real-world impact—advancing early detection, improving access to technology, and reducing disparities in care.

https://t.co/SGkACt8NnZ

#T1D #Innovation

[T1D Exchange @T1DExchange]

Every breakthrough starts with real people and real experiences.

Join the T1D Exchange Registry to help advance research and care for type 1 diabetes. Share your story, participate in studies, and make a difference: https://t.co/bHoV3H7wK9

[T1D Exchange @T1DExchange]

“How can diabetes technology be more reachable and understandable for everyone?”

Dr. Jenise Wong shares how equity, access, and connection are shaping the future of diabetes care.

Read more: https://t.co/sq12oCkrRq